Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/life11040354 http://scihub22266oqcxt.onion/10.3390/life11040354 33919577!8073137!33919577     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Life+(Basel) 2021 ; 11 (4): ä Nephropedia Template TP {{tp|p=33919577|t=2021. The Three Pillars of COVID-19 Convalescent Plasma Therapy |pdf=|usr=}}{{33919577}} gab.com Text The Three Pillars of COVID-19 Convalescent Plasma Therapy JO: Life (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33919577 #FOAvip The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly around the world in the last year causing the coronavirus disease 2019 (COVID-19), which still is a severe threat for public health. The therapeutic management of COVID-19 is challenging as, up until now, no specific and efficient pharmacological therapy has been validated. Translating the experience from previous viral epidemics, passive immunotherapy by means of plasma from individuals recovered from COVID-19 has been intensively investigated since the beginning of the pandemic. In this narrative review, we critically analyze the three factors, named "pillars", that play a key role in determining the clinical effectiveness of this biologic therapy: the convalescent plasma, the disease (COVID-19), and the patients. Twit Text FOAVip The Three Pillars of COVID-19 Convalescent Plasma Therapy ????Life (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33919577 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33919577 #FOAvip English Wikipedia <ref>{{Cite pmid|33919577}}</ref> The Three Pillars of COVID-19 Convalescent Plasma Therapy #MMPMID33919577 Franchini M; Liumbruno GM; Piacentini G; Glingani C; Zaffanello M Life (Basel) 2021[Apr]; 11 (4): ä PMID33919577show ga The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread rapidly around the world in the last year causing the coronavirus disease 2019 (COVID-19), which still is a severe threat for public health. The therapeutic management of COVID-19 is challenging as, up until now, no specific and efficient pharmacological therapy has been validated. Translating the experience from previous viral epidemics, passive immunotherapy by means of plasma from individuals recovered from COVID-19 has been intensively investigated since the beginning of the pandemic. In this narrative review, we critically analyze the three factors, named "pillars", that play a key role in determining the clinical effectiveness of this biologic therapy: the convalescent plasma, the disease (COVID-19), and the patients. äThe Three Pillars of COVID-19 Convalescent Plasma Therapy (epmc).pdf DeepDyve Pubget Overpricing